About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.11.76284338091784.4570
Domestic EquitiesCipla Ltd.8.15224151375543.6641
Domestic EquitiesMankind Pharma Ltd.7.57652248970505.2761
Domestic EquitiesDivi's Laboratories Ltd.6.0650622021404.4692
Domestic EquitiesDr. Reddy's Laboratories Ltd.5.94182995363396.2566
Domestic EquitiesBiocon Ltd.5.812810778690387.6556
Domestic EquitiesCohance Lifesciences Ltd.4.43576121393295.8163
Domestic EquitiesLupin Ltd.3.80351100365253.6561
Domestic EquitiesMedplus Health Services Ltd3.37132577876224.8295
Domestic EquitiesAlkem Laboratories Ltd.3.2414400311216.1679
Domestic EquitiesSyngene International Ltd.3.09284410523206.2581
Domestic EquitiesAkums Drugs and Pharmaceuticals Ltd.2.02472467084135.0235
Domestic EquitiesPfizer Ltd.1.9596277423130.6829
Domestic EquitiesAurobindo Pharma Ltd.1.9345928453129.0085
Domestic EquitiesAbbott India Ltd.1.882849367125.5650
Domestic EquitiesThyrocare Technologies Ltd.1.87553124484125.0731
Domestic EquitiesJ.B.Chemicals & Pharmaceuticals Ltd.1.7732578725118.2567
Domestic EquitiesAlembic Pharmaceuticals Ltd.1.74491541322116.3698
Domestic EquitiesAlivus Life Sciences Ltd.1.72381107360114.9606
Domestic EquitiesEntero Healthcare Solutions1.7153940428114.3937
Domestic EquitiesGland Pharma Ltd.1.5093574908100.6549
Domestic EquitiesBlue Jet Healthcare Ltd.1.4441216642296.3083
Domestic EquitiesZydus Lifesciences Ltd.1.3610101761790.7613
Domestic EquitiesMetropolis Healthcare Ltd.1.3083183100887.2475
Domestic EquitiesMedi Assist Healthcare Services Ltd1.2458240773983.0790
Domestic EquitiesFine Organic Industries Ltd.1.153116615376.8973
Domestic EquitiesHikal Ltd.1.1351400009475.7018
Domestic EquitiesWindlas Biotech Ltd.1.095585765173.0590
Domestic EquitiesAarti Drugs Ltd.1.0354183506269.0534
Domestic EquitiesSanofi Consumer Healthcare India Ltd1.028414396068.5811
Domestic EquitiesAnthem Biosciences Ltd0.900278984060.0357
Domestic EquitiesAstrazeneca Pharma India Ltd.0.71785828247.8670
Domestic EquitiesFDC Ltd.0.6618121095344.1332
Domestic EquitiesLaxmi Dental Ltd.0.6588220785943.9320
Domestic EquitiesShilpa Medicare Ltd.0.606699482640.4546
Domestic EquitiesNephrocare Health Services Ltd0.418252695227.8889
Domestic EquitiesSun Pharma Advanced Research Co. Ltd0.3792176777425.2862
Domestic EquitiesSenores Pharmaceuticals Ltd0.207015350213.8029
Total 96.7556 6452.5844
Cash & Cash Equivalents and Net AssetsTREPS2.1892 145.9966
Cash & Cash Equivalents and Net AssetsNet Current Assets1.0491 69.9673
Cash & Cash Equivalents and Net AssetsCash Margin - Derivatives0.0061 0.4052
Total 3.2444 216.3691
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.